C2644 Brachytx cesium-131 chloride

Brachytherapy source, cesium-131 chloride solution, per millicurie

Medically Unlikely Edits (effective October 1, 2026)

Payer policies and prior authorization for C2644

Payer coverage policies that name C2644

C2644 appears in 1 coverage policy from BlueCross BlueShield of South Carolina.

PayerPolicyRole in policyReviewedDocument
BlueCross BlueShield of South CarolinaIntracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the Brain (CAM 80145)listed, no stanceSep 1, 2026payer document

Medicaid fee-for-service

  • AZ: $84.07 (outpatient_hospital), effective Oct 1, 2018
  • IN: $0.00 (professional, Advanced Practice Nurse (85%), non-facility), effective Sep 21, 2018
  • KY: $0.00 (asc), effective Jan 1, 2026
  • MS: $86.48 (comprehensive), effective Jul 1, 2020
  • ND: $0.00 (physician), effective Aug 1, 2026
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.